Regeneron Pharmaceuticals Inc. Company
Regeneron Pharmaceuticals is a biotechnology company that invents life-transforming medicines for people with serious diseases.
On Feb. 4, Regeneron announced it is working on developing monoclonal antibodies as treatments for COVID-19. The company’s VelocImmune platform uses genetically-engineered mice with humanized immune systems in preclinical testing. “We are aiming to have hundreds of thousands of prophylactic doses ready for human testing by end of August,” a spokesperson said. Christos Kyratsous, VP of infectious disease R&D and viral vector technology, is running the project.
Connections from
Employee Number:
N/A
Funding Status:
N/A
Headquarters:
United States
Technology:
COVID
Founded Date:
N/A
Investor Type:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A
Industry:
Treatments